$113.4M
3 filings since 2024 · latest Equity filed
Rakuten Medical, Inc. is a biotechnology company focused on developing advanced cancer treatments through their innovative photoimmunotherapy technology. Their mission is to provide more precise and effective therapeutic options, specifically targeting cancer cells to minimize collateral damage to healthy tissues.
What sets it apart
The company's unique approach lies in its use of light-activated drugs combined with targeted antibodies, offering new hope for precision cancer treatment.
ASP-1929 is a pioneering cancer treatment under development that employs Rakuten Medical's photoimmunotherapy technology. This approach uses antibodies that specifically bind to cancer cells and are activated by an external light source, enhancing treatment precision.
